We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
IDEXX Laboratories Inc | NASDAQ:IDXX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.06 | 2.06% | 499.30 | 494.43 | 500.40 | 500.48 | 484.03 | 484.03 | 529,834 | 00:33:56 |
1. Name and Address of Reporting Person * AYERS JONATHAN W | 2. Issuer Name and Ticker or Trading Symbol IDEXX LABORATORIES INC /DE [ IDXX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) __X__ Other (specify below) Senior Advisor |
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security (Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 11/4/2019 | M | 53820 | A | $45.84 | 1079784 (1) | D | |||
Common Stock | 11/4/2019 | S | 23375 | D | $278.8987 (2) | 1056409 | D | |||
Common Stock | 11/4/2019 | S | 26198 | D | $279.7245 (3) | 1030211 | D | |||
Common Stock | 11/4/2019 | S | 4247 | D | $280.4656 (4) | 1025964 | D | |||
Common Stock | 11/4/2019 | S | 1891 | D | $279.4333 (5) | 1024073 | D | |||
Common Stock | 11/4/2019 | S | 3402 | D | $280.0805 (6) | 1020671 | D | |||
Common Stock | 11/4/2019 | S | 2984 | D | $281.7366 (7) | 1017687 | D | |||
Common Stock | 11/5/2019 | S | 1300 | D | $277.8715 (8) | 1016387 | D | |||
Common Stock | 11/5/2019 | S | 3839 | D | $265.3846 (9) | 1012548 | D | |||
Common Stock | 11/5/2019 | S | 11794 | D | $266.5371 (10) | 1000754 | D | |||
Common Stock | 138000 | I | by Ayers Family Trust |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Non-Qualified Stock Option (right-to-buy) | $45.84 | 11/4/2019 | M | 53820 (11) | (12) | 2/13/2020 | Common Stock | 53820 | (13) | 0 | D |
Reporting Owners |
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
AYERS JONATHAN W ONE IDEXX DRIVE WESTBROOK, ME 04092 |
X | Senior Advisor |
Signatures |
||
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers | 11/6/2019 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year IDEXX Laboratories Chart |
1 Month IDEXX Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions